ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted March 6, 2015

FDA Warns Consumers Not to Buy or Use Weight Loss Supplement Containing Hidden Drug

On March 5, 2015, the FDA warned consumers not to buy or use weight loss supplement L-Carnitine Sob Strengthening Version Slimming Miracle Capsule because it was found to contain sibutramine.

Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.

L-Carnitine Sob Strengthening Version Slimming Miracle Capsule was identified by the FDA during an examination of international mail shipments.

Consumers who have purchased this supplement should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.

See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.

See Related Warnings:

Weight Loss Supplement Contains Hidden Drug

FDA Warns of Weight Loss Supplement Dangers

FDA Warns Consumers Not to Buy or Use Weight Loss Supplement

Weight Loss Supplements Recalled

FDA Warns Some Bee Pollen Products for Weight Loss Are Dangerous

Bee Pollen and Weight Loss Supplements Recalled

FDA Warns Consumers Not To Buy Or Use Weight Loss Supplement

Recall of "Bee Pollen" Supplement Found to Contain Drug

FDA Warns Consumers of Weight Loss and Body Reshaping Supplements Containing Controlled Substance

To read the FDA's warning, use the link below.